Local immune responses correlate with presentation and outcome in tuberculosis

被引:159
作者
Condos, R
Rom, WN
Liu, YM
Schluger, NW
机构
[1] NYU, Med Ctr, Bellevue Chest Serv, New York, NY 10016 USA
[2] NYU, Med Ctr, Div Pulm & Crit Care Med, New York, NY 10016 USA
关键词
D O I
10.1164/ajrccm.157.3.9705044
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Local cellular immune responses may affect presentation and outcome in tuberculosis (TB). To investigate this hypothesis, we performed bronchoalveolar lavage (BAL) on 30 patients with untreated pulmonary tuberculosis and assessed the type of cellular inflammatory response and cytokine production. We then correlated BAL findings and cytokine production with clinical findings. We also performed BAL on a subset of patients to examine changes in cytokine production by BAL cells over time. We found that at presentation patients with less clinically and radiographically advanced TB (smear-negative, noncavitary disease) had a local immune response characterized by a predominance of lymphocytes. Furthermore, BAL cells from these patients secreted interferon (IFN gamma), and not Interleukin-4, suggesting a Th 1-type lymphocytic response. In patients with smear-positive and/or cavitary disease, macrophages or polymorphonuclear leukocytes were the predominant BAL cell type, but with treatment and clinical improvement these patients went on to recruit IFN gamma producing cells to the lung. We conclude that the type of cellular immune response that occurs locally in the lung may affect presentation and outcome in pulmonary TB, and an understanding of the development of this response may lead to insights into pathogenesis and novel therapies for TB.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 32 条
[1]   LYMPHOCYTE AND LYMPHOCYTE SUBSET NUMBERS IN BLOOD AND IN BRONCHOALVEOLAR LAVAGE AND PLEURAL FLUID IN VARIOUS FORMS OF HUMAN PULMONARY TUBERCULOSIS AT PRESENTATION AND DURING RECOVERY [J].
AINSLIE, GM ;
SOLOMON, JA ;
BATEMAN, ED .
THORAX, 1992, 47 (07) :513-518
[2]   BRONCHOSCOPY WITH BRONCHOALVEOLAR LAVAGE IN TUBERCULOSIS AND FUNGAL-INFECTIONS [J].
BAUGHMAN, RP ;
DOHN, MN ;
LOUDON, RG ;
FRAME, PT .
CHEST, 1991, 99 (01) :92-97
[3]   Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].
Condos, R ;
Rom, WN ;
Schluger, NW .
LANCET, 1997, 349 (9064) :1513-1515
[4]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[5]  
DENIS M, 1991, CLIN EXP IMMUNOL, V84, P200, DOI 10.1111/j.1365-2249.1991.tb08149.x
[6]   FACTORS INFLUENCING THE CELLULAR-RESPONSE IN BRONCHOALVEOLAR LAVAGE AND PERIPHERAL-BLOOD OF PATIENTS WITH PULMONARY TUBERCULOSIS [J].
DHAND, R ;
DE, A ;
GANGULY, NK ;
GUPTA, N ;
JASWAL, S ;
MALIK, SK ;
KOHLI, KK .
TUBERCLE, 1988, 69 (03) :161-173
[7]  
DOUVAS GS, 1985, INFECT IMMUN, V50, P1
[8]   ATTEMPTS TO CHARACTERIZE THE MECHANISMS INVOLVED IN MYCOBACTERIAL GROWTH-INHIBITION BY GAMMA-INTERFERON-ACTIVATED BONE-MARROW MACROPHAGES [J].
FLESCH, IEA ;
KAUFMANN, SHE .
INFECTION AND IMMUNITY, 1988, 56 (06) :1464-1469
[9]  
FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233
[10]   ENHANCEMENT OF INTRACELLULAR GROWTH OF MYCOBACTERIUM-TUBERCULOSIS IN HUMAN MONOCYTES BY TRANSFORMING GROWTH-FACTOR-BETA-1 [J].
HIRSCH, CS ;
YONEDA, T ;
AVERILL, L ;
ELLNER, JJ ;
TOOSSI, Z .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1229-1237